Newsfile Corp
26 Oct 2026, 09:40 UTC · 4h ago
Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 2, 2026
Impact · against what's priced in
Unicycive Therapeutics faces potential cash flow pressure and EPS drag due to a new securities class action lawsuit regarding the period between December 2025 and June 2026. This represents an unexpected legal liability that may distract management and deplete reserves.
- UNCY−0.40
No priced-in read yet





